This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Mammalian Derived Proteins Market

Market Insights on Mammalian Derived Proteins covering sales outlook, demand forecast & up-to-date key trends

Mammalian Derived Proteins Market by Product, Therapy Area Application, End User & Region - Forecast 2022 - 2032

Mammalian Derived Proteins Market Overview (2022-2032)

Expanding at a CAGR of 9.0%, the global mammalian derived proteins market is projected to increase from a valuation of US$ 588.9 Mn in 2021 to US$ 1.5 Bn by 2032.

“The increasing prevalence of cancer and fertility conditions among the population, and increasing adoption of hormonal therapies will attribute to the increase in the growth of the mammalian derived proteins market.”

The proteins that are isolated from the mammalian system are known as mammalian derived proteins. These proteins are of gold standard in therapeutic applications. Due to the highest possibility of proper binding activity, the mammalian derived proteins are highly used for the production of monoclonal antibodies (MAB), clotting factors, and hormones.

The capability of mammalian cell cultures to synthesize large and complex protein molecules and high tolerance to environmental changes is high. Thus, Mouse myeloma and Chinese hamster ovary cell systems are conventionally used for producing mammalian derived proteins.

Attributes

Details

Mammalian Derived Proteins Market Value in 2021

US$ 588.9 Mn

Mammalian Derived Proteins Market Value in 2032

US$ 1.5 Bn

Mammalian Derived Proteins Market CAGR (2022-2032)

9.0%

Customize this Report

Let us know your requirement to get
100% FREE customization

What Are The Major Drivers Boosting The Growth Rate For The Mammalian Derived Proteins Market?

The major factor driving the mammalian derived proteins market is rising prevalence of chronic diseases like cancer and cardiac disorders. This factor act as the biggest driver for the market. Additionally, the increase in the fertility problems has raised the adoption rate of hormonal therapies across the globe.

As most of the fertility hormones are developed through mammalian cell cultures, the global mammalian derived protein market is expected to propel in the near future.

Moreover, utilizing human cell lines for the production of mammalian derived proteins is popular in the industry. Technological advancements in genome engineering has developed different approaches of expression and isolation of proteins for research purpose. This will drive the mammalian derived proteins market in the projected period.

Which Region Shows Strong Growth Potential In The Mammalian Derived Proteins Market?

Owing to the technological development and premier research institutes in the U.S. and Canada, the North American region will lead the mammalian derived proteins market. Also, the growth of the mammalian derived proteins market will be triggered by the rising prevalence of chronic diseases along with the rising infertility issues among people in this region.

Following North America, Europe will lead the market to grow due to the increasing incidence of chronic illness and rising geriatric population. Additionally, strong investment in healthcare structure will boost the market for mammalian derived proteins in Europe. In East Asia, China is estimated to drive market growth with the rising prevalence of cardiovascular diseases.

Due to the less awareness among the population in the regions like Latin America, the Middle East, and Africa, the growth rate for the mammalian derived proteins market is low.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Who Are The Key Manufacturers Of The Mammalian Derived Proteins Market?

Some of the key manufacturers of mammalian derived proteins market are F. Hoffmann-La Roche Ltd, Merck KGaA, Eli Lilly and Company, Lonza., CUSABIO TECHNOLOGY LLC., Prospec-Tany Technogene Ltd., Randox Laboratories Ltd, Geno Technology Inc., Kaneka Eurogentec S.A., Batavia Biosciences., Abnova Corporation, Cayman Chemical, SOSV LLC – IndieBio, and Bioclone Inc.

Scope Of Report

Report Attributes

Details

Growth Rate

CAGR of 9.0% 2022-2032

Base Year for Estimation

2021

Historical Data

2012-2021

Forecast Period

2022-2032

Qualitative Units

Revenue in USD Million and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segment Covered

  • Product
  • Therapy Area
  • Application
  • End User
  • Region

Region Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Players

  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Eli Lilly and Company
  • Lonza.
  • CUSABIO TECHNOLOGY LLC.
  • Prospec-Tany Technogene Ltd.
  • Randox Laboratories Ltd
  • Geno Technology Inc.
  • Kaneka Eurogentec S.A.
  • Batavia Biosciences.
  • Abnova Corporation
  • Cayman Chemical
  • SOSV LLC – IndieBio
  • Bioclone Inc

Customization

Available Upon Request

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Key Segments Covered In The Mammalian Derived Proteins Industry Survey

By Product:

  • Monoclonal antibodies
  • Clotting factors
  • Hormones
  • Cytokines
  • Others

By Therapy Area:

  • Cancer Therapies
  • Myocardial Infarction
  • Congestive Heart Failure
  • Crohn’s Disease
  • Fertility Treatments
  • Haemophilia
  • Others

By Application:

  • Aptamer development
  • Western blotting
  • ELISA
  • Protein Interaction
  • Protein Structure
  • Cell culture experiments
  • Antibody profiling
  • Improved altered functions
  • Others

By End User:

  • Biotechnology companies
  • Research institutes
  • Contract Research organizations
  • Hospitals

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

The global mammalian derived proteins market is anticipated to register a CAGR of 9.0% during the forecast period.

The mammalian derived proteins market is projected to be about US$ 1.5 Bn by the end of year 2032.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Difficult-to-Express Proteins Market

Published : July 2019

Healthcare

Lipid Transfer Proteins Market

Published : July 2017

Healthcare

Extracellular Matrix Proteins Market

Published : April 2017

Healthcare

Protein Expression Market

Published : July 2020

Google translate

Mammalian Derived Proteins Market